Aker Stock Price, News & Analysis

AKER

Company Description

Aker (Nasdaq: AKER) is a publicly traded company.

AKER stock has declined 32.1% over the past year.

This page provides a comprehensive overview of AKER stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-32.14%

Performance 1 year

$0.0

Market Cap

74.3M

Shares outstanding

Aker (AKER) stock. Over the past 12 months, the stock has lost 32.1%.

Latest News

View All

April 16, 2021

-9.52%

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

acquisition

April 13, 2021

-15.19%

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial

acquisition covid-19

April 12, 2021

+8.72%

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board

management acquisition

March 22, 2021

+2.33%

Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals

February 23, 2021

-11.56%

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

February 18, 2021

-2.24%

Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission

Aker has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include acquisition, covid-19, management, earnings, conferences. View all AKER news →

SEC Filings

View All

No SEC filings available for AKER.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months